What Has Been The Evolution of the Myomectomy Market in Recent Years?
The myomectomy market has seen considerable growth due to a variety of factors.
• In recent times, the myomectomy market has witnessed robust growth. With a compound annual growth rate (CAGR) of 8.5%, it is set to escalate from $1.5 billion in 2024 to $1.62 billion in 2025.
The impressive growth observed during the historical period can be ascribed to a number of factors such as a mounting prevalence of uterine fibroids, sophisticated advancements in surgical technology, heightened consciousness regarding treatment alternatives, escalating patient demand for efficient solutions, and significant improvements in healthcare infrastructure.
What Is the Forecasted Market Size and Growth Rate for The Myomectomy Market Size In The Coming Years?
The myomectomy market is expected to maintain its strong growth trajectory in upcoming years.
• Considerable surge in the myomectomy market size is anticipated in the upcoming years, with a projection to reach $2.23 billion by 2029 while maintaining a compound annual growth rate (CAGR) of 8.2%.
Factors contributing to this positive trend during the forecast timeline include an increase in the number of women opting for fertility-preserving therapies, enhanced availability of specialized gynecological care, heightened healthcare technology investment, and an escalating prevalence of uterine disorders as well as an influx in healthcare spending on superior surgical procedures. The forecast period will also showcase notable trends such as the adoption of minimally invasive and robotic-assisted surgical procedures, incorporation of artificial intelligence in treatment planning, crafting of individualized treatment strategies centered around genetic profiling, progress in non-invasive diagnosis tools and a heightened patient demand for fertility-conservation alternatives. Furthermore, the forecast timeline will witness an enlarged global reach of cutting-edge surgical technologies, a tilt towards patient-centric care, and enhancements in post-surgery recovery.
What Factors Are Driving Growth In The Myomectomy Market?
An increase in uterine-related health issues is anticipated to drive the expansion of the myomectomy market. Such uterine disorders, which encompass fibroids, endometriosis, and uterine cancer, can cause pain, abnormal bleeding, and infertility. The increased occurrence of these disorders can be attributed to heightened awareness, delayed childbirth, hormonal imbalance, and shifts in lifestyle. Myomectomy procedure, which involves the surgical removal of fibroids while preserving the uterus, is utilized for managing these disorders. The need for such procedures is exemplified by the data revealed by Cancer Australia in January 2024, stating that uterine cancer led to 561 deaths in Australia in 2020, with predictions indicating a rise to 667 deaths by 2022. Thus, escalating rates of uterine disorders significantly contribute to the growth of the myomectomy market. Myomectomy Market Driver: The increasing preference for minimally invasive techniques is also fueling the growth of the myomectomy device market. Such surgical approaches involve the use of small incisions or natural body openings to minimize trauma during internal treatment. The advantages of these techniques include medical, financial, and aesthetic improvements, boosting their demand in diverse medical sectors. Occlusion devices, utilized in minimally invasive procedures to block blood vessels or ducts, are commonly used in cardiology or radiology for treating conditions like aneurysms and congenital heart defects. January 2023 information from Intuitive Surgical Inc. disclosed that approximately 1,875,000 surgeries were executed in 2022 with vinci surgical systems, registering an increase of around 18% from about 1,594,000 surgeries in 2021. Hence, the ongoing surge in demand for less invasive techniques is spurring the growth of the myomectomy devices market.
What Are The Main Segments Of The Global Myomectomy Market?
The myomectomy market covered in this report is segmented –
1) By Type: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy
2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products
3) By End-User: Hospitals And Clinics, Surgical Centers, Medical Device Companies, Other End-Users
Subsegments:
1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy
2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques
3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy
Pre-Book The Myomectomy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Myomectomy Market?
Key players in the myomectomy market are striving to develop sophisticated gynecological methods such as the tissue extraction system to enhance surgical outcomes and provide less invasive choices for patients undergoing myomectomy. The Tissue Extraction System is designed to aid the removal of large tissue samples during minimally invasive gynecological surgeries like myomectomy. For example, Olympus Corporation, a producer of optics and reprography products based in Japan, introduced the New Gynecologic Power Morcellator in November 2022. This Morcellation Morcellator, a component of the Olympus-contained tissue extraction system, is uniquely engineered for sophisticated gynecologic processes that involve large, calcified tissue specimens. When paired with the PneumoLiner containment device, it offers selected patients a less invasive option compared to open hysterectomy or myomectomy.
Who Are the Key Players In The Myomectomy Market?
Major companies operating in the myomectomy market are:
• AbbVie Inc.
• Medtronic plc
• Stryker Corporation
• Mayo Clinic
• Boston Scientific Corporation
• Johnson Hopkins Medicines
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Smith & Nephew plc
• Hologic Inc.
• Columbia University Irving Medical Center
• CooperSurgical Inc.
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• CONMED Corporation
• Richard Wolf GmbH
• Park Hospital
• Phoenix Medical Devices
• ERBE Elektromedizin GmbH
• Advin Health Care
• Sterling Surgicals
• LiNA Medical ApS
What Is The Most Dominant Region In The Myomectomy Market?
North America was the largest region in the myomectomy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myomectomy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
